BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16:663-678. [PMID: 12406438 DOI: 10.1053/bega.2002.0333] [Cited by in Crossref: 283] [Cited by in F6Publishing: 262] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 Pardina E, Baena-Fustegueras JA, Llamas R, Catalán R, Galard R, Lecube A, Fort JM, Llobera M, Allende H, Vargas V. Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis. Obes Surg. 2009;19:608-616. [PMID: 19301078 DOI: 10.1007/s11695-009-9827-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
2 Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S. Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res 2005;29:121S-31S. [PMID: 16344596 DOI: 10.1097/01.alc.0000189284.98684.22] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
3 Ghadimi M, Mohammadi R, Daneshzad E, Moazzami B, Mohammadpour Z. Effectiveness of dietary interventions on cardio-metabolic risk factors in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Ann Gastroenterol 2021;34:415-23. [PMID: 33948068 DOI: 10.20524/aog.2021.0601] [Reference Citation Analysis]
4 Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 2004;35:1070-82. [PMID: 15343508 DOI: 10.1016/j.humpath.2004.04.017] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 6.6] [Reference Citation Analysis]
5 Perrella A, Tarantino G, Borgia G, Conca P, Sorrentino P, Ragucci P, Vecchione R, Perrella O. Cytokine network during NASH and possible treatment selection. Hepatology;38:530-530. [DOI: 10.1053/jhep.2003.50272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Jarukamjorn K, Jearapong N, Pimson C, Chatuphonprasert W. A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice. Scientifica (Cairo) 2016;2016:5029414. [PMID: 27019761 DOI: 10.1155/2016/5029414] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
7 Norheim F, Hui ST, Kulahcioglu E, Mehrabian M, Cantor RM, Pan C, Parks BW, Lusis AJ. Genetic and hormonal control of hepatic steatosis in female and male mice. J Lipid Res 2017;58:178-87. [PMID: 27811231 DOI: 10.1194/jlr.M071522] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
8 Kim HC, Oh SM, Pan W, Ueshima H, Gu D, Chuang S, Fujiyoshi A, Li Y, Zhao L, Suh I; on behalf of the East Asian Network for Stroke Prevention Study group. Association between Alanine Aminotransferase and Intracerebral Hemorrhage in East Asian Populations. Neuroepidemiology 2013;41:131-8. [DOI: 10.1159/000353186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 de Alwis NMW, Day CP. Genes and nonalcoholic fatty liver disease. Curr Diab Rep 2008;8:156-63. [DOI: 10.1007/s11892-008-0027-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
10 Chenxu G, Minxuan X, Yuting Q, Tingting G, Jing F, Jinxiao L, Sujun W, Yongjie M, Deshuai L, Qiang L, Linfeng H, Xuyuan N, Mingxing W, Ping H, Jun T. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. Free Radical Biology and Medicine 2019;134:23-41. [DOI: 10.1016/j.freeradbiomed.2018.12.034] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
11 Yuan X, Chen J, Cheng Q, Zhao Y, Zhang P, Shao X, Bi Y, Shi X, Ding Y, Sun X, Xue B. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery. BMC Gastroenterol 2018;18:147. [PMID: 30285651 DOI: 10.1186/s12876-018-0871-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Vial P, Riquelme A, Pizarro M, Solís N, Andrés Madariaga J, Aguayo G, Duarte I, Soza A, Accatino L, Arrese M. Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. Annals of Hepatology 2006;5:25-9. [DOI: 10.1016/s1665-2681(19)32035-6] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ferolla SM, Silva LC, Ferrari Mde L, da Cunha AS, Martins Fdos S, Couto CA, Ferrari TC. Dietary approach in the treatment of nonalcoholic fatty liver disease. World J Hepatol 2015;7:2522-34. [PMID: 26523205 DOI: 10.4254/wjh.v7.i24.2522] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
14 Yang W, He Y, Liu S, Gan L, Zhang Z, Wang J, Liang J, Dong Y, Wang Q, Hou Z, Yang L. Integrative transcriptomic analysis of NAFLD animal model reveals dysregulated genes and pathways in metabolism. Gene 2016;595:99-108. [PMID: 27697615 DOI: 10.1016/j.gene.2016.09.047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
15 Abe N, Kato S, Tsuchida T, Sugimoto K, Saito R, Verschuren L, Kleemann R, Oka K. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. Biol Open 2019;8:bio041251. [PMID: 31023717 DOI: 10.1242/bio.041251] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Goodman ZD. The Impact of Obesity on Liver Histology. Clinics in Liver Disease 2014;18:33-40. [DOI: 10.1016/j.cld.2013.09.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
17 Mager DR, Iñiguez IR, Gilmour S, Yap J. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). JPEN J Parenter Enteral Nutr 2015;39:73-84. [PMID: 23976771 DOI: 10.1177/0148607113501201] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
18 Baranova A, Younossi ZM. Adipokines in Non-Alcoholic Fatty Liver Disease. In: Fantuzzi G, Mazzone T, editors. Adipose Tissue and Adipokines in Health and Disease. Totowa: Humana Press; 2007. pp. 291-305. [DOI: 10.1007/978-1-59745-370-7_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Morsy MD, Aboonq MS, ALsleem MA, Abusham AA. Taurine prevents high-fat diet-induced-hepatic steatosis in rats by direct inhibition of hepatic sterol regulatory element-binding proteins and activation of AMPK. Clin Exp Pharmacol Physiol 2020. [PMID: 32691860 DOI: 10.1111/1440-1681.13387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wei J, Lei GH, Fu L, Zeng C, Yang T, Peng SF. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults. PLoS One 2016;11:e0147985. [PMID: 26824361 DOI: 10.1371/journal.pone.0147985] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
21 Ratziu V, Poynard T. NASH: a hidden and silent fibroser finally revealed? Journal of Hepatology 2005;42:12-4. [DOI: 10.1016/j.jhep.2004.11.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
22 Liu S, Shi W, Li G, Jin B, Chen Y, Hu H, Liu L, Xie F, Chen K, Yin D. Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26:1010-5. [PMID: 21265881 DOI: 10.1111/j.1440-1746.2011.06672.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
23 Hewitt KN, Pratis K, Jones ME, Simpson ER. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology. 2004;145:1842-1848. [PMID: 14684602 DOI: 10.1210/en.2003-1369] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 7.1] [Reference Citation Analysis]
24 Najjar SM, Russo L. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol. 2014;36:55-71. [PMID: 24258517 DOI: 10.1007/s00281-013-0407-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
25 Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Metabolism. 2011;60:805-814. [PMID: 20846698 DOI: 10.1016/j.metabol.2010.07.032] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
26 Sajjad A, Mottershead M, Syn WK, Jones R, Smith S, Nwokolo CU. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2005;22:291-299. [PMID: 16097995 DOI: 10.1111/j.1365-2036.2005.02562.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
27 Tannapfel A, Denk H, Dienes H, Langner C, Schirmacher P, Trauner M, Flott-rahmel B. Histopathologische Diagnose der nichtalkoholischen und alkoholischen Fettlebererkrankung: Konsensusbasierte Leitlinie der Stufe 2. Pathologe 2010;31:225-37. [DOI: 10.1007/s00292-010-1274-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
28 Valdecantos MP, Pérez-Matute P, González-Muniesa P, Prieto-Hontoria PL, Moreno-Aliaga MJ, Martínez JA. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function. J Nutr Biochem 2012;23:1676-84. [PMID: 22464149 DOI: 10.1016/j.jnutbio.2011.11.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
29 Yener S, Akarsu M, Demir T, Akinci B, Sagol O, Bayraktar F, Ozcan MA, Tankurt E, Yesil S. Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. J Endocrinol Invest 2007;30:810-9. [DOI: 10.1007/bf03349221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
30 Furusho H, Miyauchi M, Hyogo H, Inubushi T, Ao M, Ouhara K, Hisatune J, Kurihara H, Sugai M, Hayes CN, Nakahara T, Aikata H, Takahashi S, Chayama K, Takata T. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol 2013;48:1259-70. [PMID: 23307045 DOI: 10.1007/s00535-012-0738-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
31 Amini R, Nosrati N, Yazdanparast R, Molaei M. Teucrium polium in prevention of steatohepatitis in rats. Liver International 2009;29:1216-21. [DOI: 10.1111/j.1478-3231.2009.02033.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pelz S, Stock P, Brückner S, Christ B. A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Exp Cell Res 2012;318:276-87. [PMID: 22108588 DOI: 10.1016/j.yexcr.2011.11.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
33 El Hadi H, Vettor R, Rossato M. Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? Antioxidants (Basel) 2018;7:E12. [PMID: 29337849 DOI: 10.3390/antiox7010012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 14.0] [Reference Citation Analysis]
34 Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian BR, Gura KM, Nose V, Zauscher B, Moses M, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol 2006;291:G1011-9. [PMID: 16844679 DOI: 10.1152/ajpgi.00047.2006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
35 Anstee QM, Seth D, Day CP. Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2016;150:1728-1744.e7. [PMID: 26873399 DOI: 10.1053/j.gastro.2016.01.037] [Cited by in Crossref: 121] [Cited by in F6Publishing: 107] [Article Influence: 24.2] [Reference Citation Analysis]
36 Gornicka A, Morris-Stiff G, Thapaliya S, Papouchado BG, Berk M, Feldstein AE. Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis. Antioxid Redox Signal 2011;15:437-45. [PMID: 21194384 DOI: 10.1089/ars.2010.3815] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
37 Esteban-Zubero E, García-Gil FA, López-Pingarrón L, Alatorre-Jiménez MA, Ramírez JM, Tan DX, García JJ, Reiter RJ. Melatonin role preventing steatohepatitis and improving liver transplantation results. Cell Mol Life Sci 2016;73:2911-27. [PMID: 27022943 DOI: 10.1007/s00018-016-2185-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
38 Herrigel DJ, Moss RA. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. Postgrad Med. 2014;126:106-118. [PMID: 25414939 DOI: 10.3810/pgm.2014.10.2825] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
39 Susutlertpanya W, Werawatganon D, Siriviriyakul P, Klaikeaw N. Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model. Evid Based Complement Alternat Med. 2015;2015:509057. [PMID: 26246839 DOI: 10.1155/2015/509057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
40 Esteghamati A, Jamali A, Khalilzadeh O, Noshad S, Khalili M, Zandieh A, Morteza A, Nakhjavani M. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetol Metab Syndr. 2010;2:65. [PMID: 21047423 DOI: 10.1186/1758-5996-2-65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
41 Del Ben M, Baratta F, Polimeni L, Pastori D, Loffredo L, Averna M, Violi F, Angelico F. Under-prescription of statins in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2017;27:161-7. [PMID: 27914698 DOI: 10.1016/j.numecd.2016.09.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
42 Hormoznejad R, Mohammad Shahi M, Rahim F, Helli B, Alavinejad P, Sharhani A. Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial. Int J Food Sci Nutr 2020;71:991-1000. [PMID: 32237922 DOI: 10.1080/09637486.2020.1746957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ong JP, Younossi ZM. Approach to the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2005;9:617-34. [DOI: 10.1016/j.cld.2005.07.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
44 Méndez-sánchez N, Sánchez-castillo CP, Villa AR, Madrigal H, Merino B, García E, López P, Pichardo-ontiveros E, Uribe M. The Relationship of Overweight and Obesity to High Mortality Rates from Liver Cirrhosis in Mexico. Annals of Hepatology 2004;3:66-71. [DOI: 10.1016/s1665-2681(19)32111-8] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
45 Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr. 2009;139:905-911. [PMID: 19321579 DOI: 10.3945/jn.108.101808] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 12.4] [Reference Citation Analysis]
46 Page AJ, Kooby DA. Perioperative management of hepatic resection. J Gastrointest Oncol 2012;3:19-27. [PMID: 22811866 DOI: 10.3978/j.issn.2078-6891.2012.005] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
47 Isaksen VT, Larsen MA, Goll R, Florholmen JR, Paulssen EJ. Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects. BMC Obes 2016;3:39. [PMID: 27672441 DOI: 10.1186/s40608-016-0118-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Na H, Lee H, Lee MH, Lim HJ, Kim HJ, Jeon Y, Kang HL, Lee MO. Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis. Life Sci 2016;166:13-9. [PMID: 27720799 DOI: 10.1016/j.lfs.2016.10.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Del Ben M, Polimeni L, Carnevale R, Bartimoccia S, Nocella C, Baratta F, Loffredo L, Pignatelli P, Violi F, Angelico F. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2014;14:81. [PMID: 24758604 DOI: 10.1186/1471-230x-14-81] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
50 Yu J, Marsh S, Hu J, Feng W, Wu C. The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterol Res Pract. 2016;2016:2862173. [PMID: 27247565 DOI: 10.1155/2016/2862173] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 11.4] [Reference Citation Analysis]
51 Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, Parra M, González de la Presa B, Ribera J, Pastor Ó, Morales-Ruíz M, Puntes V, Jiménez W. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Sci Rep 2019;9:12848. [PMID: 31492960 DOI: 10.1038/s41598-019-49262-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
52 Miquilena Colina ME, García Monzón C. [Obesity and liver disease]. Gastroenterol Hepatol 2010;33:591-604. [PMID: 20206411 DOI: 10.1016/j.gastrohep.2009.12.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Ong JP, Younossi ZM. Epidemiology and Natural History of NAFLD and NASH. Clinics in Liver Disease 2007;11:1-16. [DOI: 10.1016/j.cld.2007.02.009] [Cited by in Crossref: 292] [Cited by in F6Publishing: 264] [Article Influence: 20.9] [Reference Citation Analysis]
54 Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci. 2016;73:1969-1987. [PMID: 26894897 DOI: 10.1007/s00018-016-2161-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 18.2] [Reference Citation Analysis]
55 Yue Y, Liu X, Li Y, Xia B, Yu W. The role of TLR4/MyD88/NF-κB pathway in periodontitis-induced liver inflammation of rats. Oral Dis 2021;27:1012-21. [PMID: 32853444 DOI: 10.1111/odi.13616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Omagari K, Kato S, Tsuneyama K, Hatta H, Sato M, Hamasaki M, Sadakane Y, Tashiro T, Fukuhata M, Miyata Y, Tamaru S, Tanaka K, Mune M. Olive leaf extract prevents spontaneous occurrence of non-alcoholic steatohepatitis in SHR/NDmcr-cp rats. Pathology 2010;42:66-72. [PMID: 20025483 DOI: 10.3109/00313020903434389] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
57 Bilgir O, Bilgir F, Bozkaya G, Calan M. Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease. Blood Coagulation & Fibrinolysis 2014;25:151-5. [DOI: 10.1097/mbc.0000000000000009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
58 Alwayn IPJ, Gura K, Nosé V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M. Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease. Pediatr Res 2005;57:445-52. [DOI: 10.1203/01.pdr.0000153672.43030.75] [Cited by in Crossref: 153] [Cited by in F6Publishing: 41] [Article Influence: 9.6] [Reference Citation Analysis]
59 Marra F. NASH: are genes blowing the hits? Journal of Hepatology 2004;40:853-6. [DOI: 10.1016/j.jhep.2004.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
60 Eslamparast T, Tandon P, Raman M. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients. 2017;9. [PMID: 28933748 DOI: 10.3390/nu9080800] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
61 McKenzie J, Fisher BM, Jaap AJ, Stanley A, Paterson K, Sattar N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2006;65:40-44. [PMID: 16817817 DOI: 10.1111/j.1365-2265.2006.02543.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
62 An J, Cheng L, Yang L, Song N, Zhang J, Ma K, Ma J. P- Hydroxybenzyl Alcohol Alleviates Oxidative Stress in a Nonalcoholic Fatty Liver Disease Larval Zebrafish Model and a BRL-3A Hepatocyte Via the Nrf2 Pathway. Front Pharmacol 2021;12:646239. [PMID: 33912056 DOI: 10.3389/fphar.2021.646239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Swapna Sasi US, Sindhu G, Raghu KG. Fructose-palmitate based high calorie induce steatosis in HepG2 cells via mitochondrial dysfunction: An in vitro approach. Toxicol In Vitro 2020;68:104952. [PMID: 32730863 DOI: 10.1016/j.tiv.2020.104952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Huff M, da Silveira W, Starr Hazard E, Courtney SM, Renaud L, Hardiman G. Systems analysis of the liver transcriptome in adult male zebrafish exposed to the non-ionic surfactant nonylphenol. General and Comparative Endocrinology 2019;271:1-14. [DOI: 10.1016/j.ygcen.2018.10.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
65 Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis. 2007;11:75-104, ix. [PMID: 17544973 DOI: 10.1016/j.cld.2007.02.011] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 7.4] [Reference Citation Analysis]
66 Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, Pacilio M, Amitrano M, Capuano G, Meli R. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr. 2005;147:62-66. [PMID: 16027697 DOI: 10.1016/j.jpeds.2005.02.028] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
67 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011;458:511-523. [PMID: 21442288 DOI: 10.1007/s00428-011-1066-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 6.9] [Reference Citation Analysis]
68 Weston CJ, Adams DH. Hepatic consequences of vascular adhesion protein-1 expression. J Neural Transm 2011;118:1055-64. [DOI: 10.1007/s00702-011-0647-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
69 Peng Y, Li Y, He Y, Wei Q, Xie Q, Zhang L, Xia Y, Zhou X, Zhang L, Feng X, Chen K, Chen S, Chen W, Long Q, Chai J. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. Expert Rev Gastroenterol Hepatol. 2018;12:503-513. [PMID: 29629626 DOI: 10.1080/17474124.2018.1463158] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
70 Cobbold JFL, Anstee QM, Taylor-robinson SD. The importance of fatty liver disease in clinical practice. Proc Nutr Soc 2010;69:518-27. [DOI: 10.1017/s0029665110001916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
71 Cortez-pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: From cell biology to clinical practice. Journal of Hepatology 2006;44:197-208. [DOI: 10.1016/j.jhep.2005.09.002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 123] [Article Influence: 9.3] [Reference Citation Analysis]
72 Lake AD, Novak P, Fisher CD, Jackson JP, Hardwick RN, Billheimer DD, Klimecki WT, Cherrington NJ. Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos. 2011;39:1954-1960. [PMID: 21737566 DOI: 10.1124/dmd.111.040592] [Cited by in Crossref: 107] [Cited by in F6Publishing: 101] [Article Influence: 10.7] [Reference Citation Analysis]
73 Athinarayanan S, Liu W. Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis. Med Chem (Los Angeles) 2012;2:e104. [PMID: 24660114 DOI: 10.4172/2161-0444.1000e104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
74 Izdebska M, Piątkowska-chmiel I, Korolczuk A, Herbet M, Gawrońska-grzywacz M, Gieroba R, Sysa M, Czajkowska-bania K, Cygal M, Korga A, Dudka J. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells. Can J Physiol Pharmacol 2017;95:1442-53. [DOI: 10.1139/cjpp-2016-0561] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
75 Anstee QM, Daly AK, Day CP. Genetic modifiers of non-alcoholic fatty liver disease progression. Biochim Biophys Acta. 2011;1812:1557-1566. [PMID: 21840395 DOI: 10.1016/j.bbadis.2011.07.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
76 Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006;22:437-443. [PMID: 16832839 DOI: 10.1002/dmrr.666] [Cited by in Crossref: 214] [Cited by in F6Publishing: 191] [Article Influence: 14.3] [Reference Citation Analysis]
77 Li J, Sapper TN, Mah E, Moller MV, Kim JB, Chitchumroonchokchai C, McDonald JD, Bruno RS. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability. J Nutr Biochem 2017;41:34-41. [PMID: 28038359 DOI: 10.1016/j.jnutbio.2016.12.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
78 Del Ben M, Polimeni L, Brancorsini M, Di Costanzo A, D'Erasmo L, Baratta F, Loffredo L, Pastori D, Pignatelli P, Violi F, Arca M, Angelico F. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. Eur J Intern Med. 2014;25:566-570. [PMID: 24947770 DOI: 10.1016/j.ejim.2014.05.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
79 Polimeni L, Del Ben M, Baratta F, Perri L, Albanese F, Pastori D, Violi F, Angelico F. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol. 2015;7:1325-1336. [PMID: 26052378 DOI: 10.4254/wjh.v7.i10.1325] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 16.0] [Reference Citation Analysis]
80 Park H, Jang JE, Ko MS, Woo SH, Kim BJ, Kim HS, Park HS, Park I, Koh EH, Lee K. Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice. Diabetes Metab J 2016;40:376. [DOI: 10.4093/dmj.2016.40.5.376] [Cited by in Crossref: 99] [Cited by in F6Publishing: 35] [Article Influence: 19.8] [Reference Citation Analysis]
81 Mager DR, Roberts EA. Nonalcoholic Fatty Liver Disease in Children. Clinics in Liver Disease 2006;10:109-31. [DOI: 10.1016/j.cld.2005.10.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
82 Nabil M, El Demellawy MA, Mahmoud MF, Mahmoud AAA. Prolonged overnutrition with fructose or fat induces metabolic derangements in rats by disrupting the crosstalk between the hypothalamus and periphery: Possible amelioration with fenofibrate. Eur J Pharmacol 2020;879:173136. [PMID: 32360834 DOI: 10.1016/j.ejphar.2020.173136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
83 Brunt EM. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Seminars in Diagnostic Pathology 2005;22:330-8. [DOI: 10.1053/j.semdp.2006.04.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
84 Koek G, Liedorp P, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clinica Chimica Acta 2011;412:1297-305. [DOI: 10.1016/j.cca.2011.04.013] [Cited by in Crossref: 202] [Cited by in F6Publishing: 184] [Article Influence: 20.2] [Reference Citation Analysis]
85 Liu L, Zhao X, Wang Q, Sun X, Xia L, Wang Q, Yang B, Zhang Y, Montgomery S, Meng H. Prosteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement System. Sci Rep. 2016;6:31763. [PMID: 27550859 DOI: 10.1038/srep31763] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
86 Kim S, Park S, Kim B, Kwon J. Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease. Sci Rep. 2016;6:27849. [PMID: 27279075 DOI: 10.1038/srep27849] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
87 Brouwers B, Hesselink MK, Schrauwen P, Schrauwen-Hinderling VB. Effects of exercise training on intrahepatic lipid content in humans. Diabetologia 2016;59:2068-79. [PMID: 27393135 DOI: 10.1007/s00125-016-4037-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
88 Dorling JL, Ravussin E, Redman LM, Bhapkar M, Huffman KM, Racette SB, Das SK, Apolzan JW, Kraus WE, Höchsmann C, Martin CK; CALERIE Phase 2 Study Group. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. Eur J Nutr 2021;60:1633-43. [PMID: 32803412 DOI: 10.1007/s00394-020-02361-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, Luzza F. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. Nutrients 2017;9:E870. [PMID: 28805669 DOI: 10.3390/nu9080870] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
90 Demir M, Lang S, Steffen HM. Nonalcoholic fatty liver disease - current status and future directions. J Dig Dis 2015;16:541-57. [PMID: 26406351 DOI: 10.1111/1751-2980.12291] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
91 Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. Nutrients. 2014;6:5583-5599. [PMID: 25479248 DOI: 10.3390/nu6125583] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
92 Hemmeryckx B, Gaekens M, Gallacher DJ, Lu HR, Lijnen HR. Effect of rosiglitazone on liver structure and function in genetically diabetic Akita mice. Basic Clin Pharmacol Toxicol 2013;113:353-60. [PMID: 23789962 DOI: 10.1111/bcpt.12104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
93 Zein CO, Lopez R, Fu X, Kirwan JP, Yerian LM, McCullough AJ, Hazen SL, Feldstein AE. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. Hepatology. 2012;56:1291-1299. [PMID: 22505276 DOI: 10.1002/hep.25778] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 12.5] [Reference Citation Analysis]
94 Azeemuddin M, Rafiq M, Anturlikar SD, Sharath Kumar LM, Patki PS, Babu UV, Shyam R. Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis. J Tradit Complement Med 2016;6:160-7. [PMID: 27114939 DOI: 10.1016/j.jtcme.2014.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Ibañez P, Solis N, Pizarro M, Aguayo G, Duarte I, Miquel JF, Accatino L, Arrese M. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2007;22:846-51. [PMID: 17565640 DOI: 10.1111/j.1440-1746.2006.04700.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
96 Streba LA, Vere CC, Rogoveanu I, Streba CT. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. World J Gastroenterol. 2015;21:4103-4110. [PMID: 25892859 DOI: 10.3748/wjg.v21.i14.4103] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 69] [Article Influence: 16.6] [Reference Citation Analysis]
97 Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol. 2015;7:559-565. [PMID: 25848479 DOI: 10.4254/wjh.v7.i3.559] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
98 Wickliffe JK, Dertinger SD, Torous DK, Avlasevich SL, Simon-Friedt BR, Wilson MJ. Diet-induced obesity increases the frequency of Pig-a mutant erythrocytes in male C57BL/6J mice. Environ Mol Mutagen 2016;57:668-77. [PMID: 27739633 DOI: 10.1002/em.22058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
99 Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol. 2007;22:2009-2014. [PMID: 17914984 DOI: 10.1111/j.1440-1746.2006.04681.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
100 Sun WW, ShangGuan T, Zhu P, Li HK, Jiang M, Yang P, Li LY, Zhang ZH. Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis. Life Sci 2020;245:117356. [PMID: 31991181 DOI: 10.1016/j.lfs.2020.117356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Kuraji R, Ito H, Fujita M, Ishiguro H, Hashimoto S, Numabe Y. Porphyromonas gingivalis induced periodontitis exacerbates progression of non-alcoholic steatohepatitis in rats. Clin Exp Dent Res 2016;2:216-25. [PMID: 29744170 DOI: 10.1002/cre2.41] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
102 Yoneda M, Hasegawa T, Sato K. Vitamin E therapy for NAFLD/NASH. Nutrition 2015;31:898-9. [PMID: 25933501 DOI: 10.1016/j.nut.2014.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
103 Ishihara K, Miyazaki A, Nabe T, Fushimi H, Iriyama N, Kanai S, Sato T, Uozumi N, Shimizu T, Akiba S. Group IVA phospholipase A 2 participates in the progression of hepatic fibrosis. FASEB j 2012;26:4111-21. [DOI: 10.1096/fj.12-205625] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
104 Jiang M, Wu N, Chen X, Wang W, Chu Y, Liu H, Li W, Chen D, Li X, Xu B. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. J Int Med Res 2019;47:1453-66. [PMID: 30871397 DOI: 10.1177/0300060519833527] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
105 Yu J, Ip E, Dela Pena A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology. 2006;43:826-836. [PMID: 16557554 DOI: 10.1002/hep.21108] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 7.6] [Reference Citation Analysis]
106 Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol 2012;56:448-54. [PMID: 21756849 DOI: 10.1016/j.jhep.2011.05.029] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 10.7] [Reference Citation Analysis]
107 Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child 2004;89:648-52. [PMID: 15210498 DOI: 10.1136/adc.2003.029942] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
108 Liu J. Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol. 2014;20:14672-14685. [PMID: 25356030 DOI: 10.3748/wjg.v20.i40.14672] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 48] [Article Influence: 10.0] [Reference Citation Analysis]
109 Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology. 2007;46:723-729. [PMID: 17680648 DOI: 10.1002/hep.21742] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
110 Ismail RS, El-Megeid AA, Abdel-Moemin AR. Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status. Ger Med Sci 2009;7:Doc05. [PMID: 19675745 DOI: 10.3205/000064] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
111 Zheng Y, Liu T, Wang Z, Xu Y, Zhang Q, Luo D. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice. International Journal of Biological Macromolecules 2018;112:929-36. [DOI: 10.1016/j.ijbiomac.2018.02.072] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
112 Müller MF, Kendall TJ, Adams DJ, Zhou Y, Arends MJ. The murine hepatic sequelae of long-term ethanol consumption are sex-specific and exacerbated by Aldh1b1 loss. Experimental and Molecular Pathology 2018;105:63-70. [DOI: 10.1016/j.yexmp.2018.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
113 Karrar A, Stepanova M, Alaparthi L, Lingam S, Younoszai Z, Zheng L, Malik KS, Younossi E, Monge F, Hunt SL. Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2015;30:900-908. [PMID: 25469790 DOI: 10.1111/jgh.12856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011;458:511-523. [PMID: 21442288 DOI: 10.1007/s00428-011-1066-1].] [Reference Citation Analysis]
115 Wan X, Xu C, Yu C, Li Y. Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH. Can J Gastroenterol Hepatol 2016;2016:6489012. [PMID: 27446858 DOI: 10.1155/2016/6489012] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 10.4] [Reference Citation Analysis]
116 Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005;4:10. [PMID: 16375767 DOI: 10.1186/1476-5926-4-10] [Cited by in Crossref: 201] [Cited by in F6Publishing: 185] [Article Influence: 12.6] [Reference Citation Analysis]
117 Sayej WN, Knight Iii PR, Guo WA, Mullan B, Ohtake PJ, Davidson BA, Khan A, Baker RD, Baker SS. Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice. Biomed Res Int. 2016;2016:7867852. [PMID: 26942201 DOI: 10.1155/2016/7867852] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
118 Chen Y, Johansson E, Yang Y, Miller ML, Shen D, Orlicky DJ, Shertzer HG, Vasiliou V, Nebert DW, Dalton TP. Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis. J Hepatol 2010;53:1085-94. [PMID: 20810184 DOI: 10.1016/j.jhep.2010.05.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
119 Ravi Kanth VV, Sasikala M, Sharma M, Rao PN, Reddy DN. Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management. World J Hepatol. 2016;8:827-837. [PMID: 27458502 DOI: 10.4254/wjh.v8.i20.827] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
120 Holmuhamedov E, Lemasters JJ. Ethanol exposure decreases mitochondrial outer membrane permeability in cultured rat hepatocytes. Arch Biochem Biophys 2009;481:226-33. [PMID: 19014900 DOI: 10.1016/j.abb.2008.10.036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
121 Kim M, Choi S. Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease? Applied Sciences 2021;11:218. [DOI: 10.3390/app11010218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Imajo K, Yoneda M, Kessoku T, Ogawa Y, Maeda S, Sumida Y, Hyogo H, Eguchi Y, Wada K, Nakajima A. Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Int J Mol Sci. 2013;14:21833-21857. [PMID: 24192824 DOI: 10.3390/ijms141121833] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
123 Park HJ, Lee JY, Chung MY, Park YK, Bower AM, Koo SI, Giardina C, Bruno RS. Green tea extract suppresses NFκB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr. 2012;142:57-63. [PMID: 22157544 DOI: 10.3945/jn.111.148544] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 9.3] [Reference Citation Analysis]
124 Fuchs CD, Krivanec S, Steinacher D, Mlitz V, Wahlström A, Stahlman M, Claudel T, Scharnagl H, Stojakovic T, Marschall HU, Trauner M. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice. Liver Int 2020;40:1366-77. [PMID: 32141703 DOI: 10.1111/liv.14423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
125 Barzegar-Amini M, Ghazizadeh H, Seyedi SMR, Sadeghnia HR, Mohammadi A, Hassanzade-Daloee M, Barati E, Kharazmi-Khorassani S, Kharazmi-Khorassani J, Mohammadi-Bajgiran M, Tavallaie S, Ferns GA, Mouhebati M, Ebrahimi M, Tayefi M, Ghayour-Mobarhan M. Serum vitamin E as a significant prognostic factor in patients with dyslipidemia disorders. Diabetes Metab Syndr 2019;13:666-71. [PMID: 30641786 DOI: 10.1016/j.dsx.2018.11.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
126 Carillon J, Romain C, Bardy G, Fouret G, Feillet-coudray C, Gaillet S, Lacan D, Cristol J, Rouanet J. Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide dismutase. Free Radical Biology and Medicine 2013;65:254-61. [DOI: 10.1016/j.freeradbiomed.2013.06.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
127 Wei Z, Xue Y, Xue Y, Cheng J, Lv G, Chu L, Ma Z, Guan S. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways. J Pharmacol Sci 2021;147:72-80. [PMID: 34294375 DOI: 10.1016/j.jphs.2021.05.006] [Reference Citation Analysis]
128 Sommer J, Mahli A, Freese K, Schiergens TS, Kuecuekoktay FS, Teufel A, Thasler WE, Müller M, Bosserhoff AK, Hellerbrand C. Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice. Oncotarget 2017;8:13059-72. [PMID: 28055957 DOI: 10.18632/oncotarget.14371] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
129 Liao YJ, Lin MW, Yen CH, Lin YT, Wang CK, Huang SF, Chen KH, Yang CP, Chen TL, Hou MF, Arthur Chen YM. Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody. PLoS One 2013;8:e77586. [PMID: 24147030 DOI: 10.1371/journal.pone.0077586] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
130 Mass Sanchez PB, Krizanac M, Weiskirchen R, Asimakopoulos A. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights. Int J Mol Sci 2021;22:5284. [PMID: 34067931 DOI: 10.3390/ijms22105284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Song HR, Yun KE, Park HS. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr 2008;88:16-21. [PMID: 18614719 DOI: 10.1093/ajcn/88.1.16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
132 Yu J, Wu CW, Chu ES, Hui AY, Cheng AS, Go MY, Ching AK, Chui YL, Chan HL, Sung JJ. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice. Biochem Biophys Res Commun. 2008;372:571-577. [PMID: 18503750 DOI: 10.1016/j.bbrc.2008.05.069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
133 Marcolin E, Forgiarini LF, Rodrigues G, Tieppo J, Borghetti GS, Bassani VL, Picada JN, Marroni NP. Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis. Basic Clin Pharmacol Toxicol. 2013;112:385-391. [PMID: 23331460 DOI: 10.1111/bcpt.12049] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
134 Verboven K, Hansen D, Jocken JWE, Blaak EE. Natriuretic peptides in the control of lipid metabolism and insulin sensitivity. Obes Rev 2017;18:1243-59. [PMID: 28901677 DOI: 10.1111/obr.12598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
135 Yokoyama H, Hirose H, Ohgo H, Saito I. Inverse association between serum adiponectin level and transaminase activities in Japanese male workers. J Hepatol. 2004;41:19-24. [PMID: 15246202 DOI: 10.1016/j.jhep.2004.03.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
136 Ratziu V, Martin L, Fedchuk L, Poynard T. Can nonalcoholic steatohepatitis be diagnosed without liver biopsy? Biomark Med 2009;3:353-61. [PMID: 20477484 DOI: 10.2217/bmm.09.36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
137 Hammes TO, Pedroso GL, Hartmann CR, Escobar TDC, Fracasso LB, da Rosa DP, Marroni NP, Porawski M, da Silveira TR. The Effect of Taurine on Hepatic Steatosis Induced by Thioacetamide in Zebrafish (Danio rerio). Dig Dis Sci 2012;57:675-82. [DOI: 10.1007/s10620-011-1931-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
138 Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32:297-302. [PMID: 22097893 DOI: 10.1111/j.1478-3231.2011.02639.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 13.5] [Reference Citation Analysis]
139 Schultz A, Neil D, Aguila MB, Mandarim-de-Lacerda CA. Hepatic adverse effects of fructose consumption independent of overweight/obesity. Int J Mol Sci 2013;14:21873-86. [PMID: 24196354 DOI: 10.3390/ijms141121873] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 7.6] [Reference Citation Analysis]
140 Arsenault DA, Potemkin AK, Robinson EM, Fallon EM, Ozonoff A, de Meijer VE, Puder M. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury. J Pediatr Surg. 2011;46:122-127. [PMID: 21238652 DOI: 10.1016/j.jpedsurg.2010.09.072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
141 Qu S, Su D, Altomonte J, Kamagate A, He J, Perdomo G, Tse T, Jiang Y, Dong HH. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab 2007;292:E421-34. [PMID: 16985262 DOI: 10.1152/ajpendo.00157.2006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
142 Seko Y, Sumida Y, Sasaki K, Itoh Y, Iijima H, Hashimoto T, Ishii S, Inagaki N. Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials. J Gastroenterol 2018;53:140-51. [DOI: 10.1007/s00535-017-1364-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
143 Abd El-Kader SM, Al-Jiffri OH, Al-Shreef FM. Markers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients. Afr Health Sci 2014;14:551-7. [PMID: 25352871 DOI: 10.4314/ahs.v14i3.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
144 Cengiz M, Candır BA, Yılmaz G, Akyol G, Ozenirler S. Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? World J Gastroenterol 2013;19:7412-8. [PMID: 24259972 DOI: 10.3748/wjg.v19.i42.7412] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
145 Park HJ, DiNatale DA, Chung MY, Park YK, Lee JY, Koo SI, O'Connor M, Manautou JE, Bruno RS. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. J Nutr Biochem 2011;22:393-400. [PMID: 20655714 DOI: 10.1016/j.jnutbio.2010.03.009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 9.4] [Reference Citation Analysis]
146 Wenfeng Z, Yakun W, Di M, Jianping G, Chuanxin W, Chun H. Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. Annals of Hepatology 2014;13:489-95. [DOI: 10.1016/s1665-2681(19)31247-5] [Cited by in Crossref: 58] [Article Influence: 8.3] [Reference Citation Analysis]
147 Hodges JK, Sasaki GY, Bruno RS. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. J Nutr Biochem 2020;85:108478. [PMID: 32801031 DOI: 10.1016/j.jnutbio.2020.108478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
148 Ferolla SM, Couto CA, Costa-Silva L, Armiliato GN, Pereira CA, Martins FS, Ferrari Mde L, Vilela EG, Torres HO, Cunha AS, Ferrari TC. Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients 2016;8:E397. [PMID: 27367724 DOI: 10.3390/nu8070397] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
149 Inafuku M, Matsuzaki G, Oku H. Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice. PLoS One 2015;10:e0128676. [PMID: 26039731 DOI: 10.1371/journal.pone.0128676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
150 Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013;5:1544-60. [PMID: 23666091 DOI: 10.3390/nu5051544] [Cited by in Crossref: 406] [Cited by in F6Publishing: 352] [Article Influence: 50.8] [Reference Citation Analysis]
151 Halsted C, Medici V, Esfandiari F. Influence of Alcohol on Folate Status and Methionine Metabolism in Relation to Alcoholic Liver Disease. In: Bailey L, editor. Folate in Health and Disease, Second Edition. CRC Press; 2009. pp. 429-48. [DOI: 10.1201/9781420071252-c17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
152 Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1-16. [PMID: 16436109 DOI: 10.1111/j.0959-9673.2006.00465.x] [Cited by in Crossref: 487] [Cited by in F6Publishing: 456] [Article Influence: 32.5] [Reference Citation Analysis]
153 Yang M, Bose S, Lim S, Seo J, Shin J, Lee D, Chung WH, Song EJ, Nam YD, Kim H. Beneficial Effects of Newly Isolated Akkermansia muciniphila Strains from the Human Gut on Obesity and Metabolic Dysregulation. Microorganisms 2020;8:E1413. [PMID: 32937828 DOI: 10.3390/microorganisms8091413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
154 Sato K, Gosho M, Yamamoto T, Kobayashi Y, Ishii N, Ohashi T, Nakade Y, Ito K, Fukuzawa Y, Yoneda M. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Nutrition. 2015;31:923-930. [PMID: 26059365 DOI: 10.1016/j.nut.2014.11.018] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 13.1] [Reference Citation Analysis]
155 Wang JW, Wan XY, Zhu HT, Lu C, Yu WL, Yu CH, Shen Z, Li YM. Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells. PLoS One 2014;9:e96124. [PMID: 24788149 DOI: 10.1371/journal.pone.0096124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
156 Ninomiya M, Kondo Y, Shimosegawa T. Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis. ISRN Hepatol 2013;2013:237870. [PMID: 27335818 DOI: 10.1155/2013/237870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Willmes DM, Kurzbach A, Henke C, Schumann T, Zahn G, Heifetz A, Jordan J, Helfand SL, Birkenfeld AL. The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target. Pharmacology & Therapeutics 2018;185:1-11. [DOI: 10.1016/j.pharmthera.2017.10.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
158 Gasparin FRS, Carreño FO, Mewes JM, Gilglioni EH, Pagadigorria CLS, Natali MRM, Utsunomiya KS, Constantin RP, Ouchida AT, Curti C, Gaemers IC, Elferink RPJO, Constantin J, Ishii-iwamoto EL. Sex differences in the development of hepatic steatosis in cafeteria diet-induced obesity in young mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:2495-509. [DOI: 10.1016/j.bbadis.2018.04.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
159 Liao YJ, Chen TL, Lee TS, Wang HA, Wang CK, Liao LY, Liu RS, Huang SF, Chen YM. Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis. Mol Med 2012;18:412-22. [PMID: 22183894 DOI: 10.2119/molmed.2011.00258] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
160 Pizarro M, Balasubramaniyan N, Solís N, Solar A, Duarte I, Miquel JF, Suchy FJ, Trauner M, Accatino L, Ananthanarayanan M, Arrese M. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut 2004;53:1837-43. [PMID: 15542525 DOI: 10.1136/gut.2003.037689] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
161 Goel R, Boylan B, Gruman L, Newman PJ, North PE, Newman DK. The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G1205-14. [PMID: 17932230 DOI: 10.1152/ajpgi.00157.2007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
162 Suter PM. Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci. 2005;42:197-227. [PMID: 16047538 DOI: 10.1080/10408360590913542] [Cited by in Crossref: 139] [Cited by in F6Publishing: 105] [Article Influence: 8.7] [Reference Citation Analysis]
163 Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. Front Med (Lausanne) 2021;8:595371. [PMID: 33718398 DOI: 10.3389/fmed.2021.595371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
164 Feld JJ, Liang TJ. Hepatitis C — identifying patients with progressive liver injury. Hepatology 2006;43:S194-206. [DOI: 10.1002/hep.21065] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
165 Wang B, Fu J, Li L, Gong D, Wen X, Yu P, Zeng Z. Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis. Int J Food Sci Nutr 2016;67:288-97. [PMID: 26932533 DOI: 10.3109/09637486.2016.1153611] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
166 Attia A, Ragheb A, Sylwestrowicz T, Shoker A. Attenuation of high cholesterol-induced oxidative stress in rabbit liver by thymoquinone: . European Journal of Gastroenterology & Hepatology 2010;22:826-34. [DOI: 10.1097/meg.0b013e328336000d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
167 Alkhouri N, McCullough AJ. Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD. Gastroenterol Hepatol (N Y). 2012;8:661-668. [PMID: 24683373 DOI: 10.1016/s0016-5085(10)62097-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Marra F, Aleffi S, Bertolani C, Petrai I, Vizzutti F. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005;22:44-7. [DOI: 10.1111/j.1365-2036.2005.02595.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
169 Kim S, Lee D, Kim J, Kim J, Park J, Lee J, Kwon J. Viscothionin Isolated from Korean Mistletoe Improves Nonalcoholic Fatty Liver Disease via the Activation of Adenosine Monophosphate-Activated Protein Kinase. J Agric Food Chem 2014;62:11876-83. [DOI: 10.1021/jf503535s] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
170 Ansari A, Bose S, Patra JK, Shin NR, Lim DW, Kim KW, Wang JH, Kim YM, Chin YW, Kim H. A Controlled Fermented Samjunghwan Herbal Formula Ameliorates Non-alcoholic Hepatosteatosis in HepG2 Cells and OLETF Rats. Front Pharmacol 2018;9:596. [PMID: 29971000 DOI: 10.3389/fphar.2018.00596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
171 Sousa-Victor P, Neves J, Cedron-Craft W, Ventura PB, Liao CY, Riley RR, Soifer I, van Bruggen N, Kolumam GA, Villeda SA, Lamba DA, Jasper H. MANF regulates metabolic and immune homeostasis in ageing and protects against liver damage. Nat Metab. 2019;1:276-290. [PMID: 31489403 DOI: 10.1038/s42255-018-0023-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
172 Roberts EA. Non-alcoholic steatohepatitis in children. Clin Liver Dis. 2007;11:155-172, x. [PMID: 17544977 DOI: 10.1016/j.cld.2007.02.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
173 Puppala J, Siddapuram SP, Akka J, Munshi A. Genetics of nonalcoholic Fatty liver disease: an overview. J Genet Genomics. 2013;40:15-22. [PMID: 23357341 DOI: 10.1016/j.jgg.2012.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
174 Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis. 2004;8:639-671. [PMID: 15331068 DOI: 10.1016/j.cld.2004.04.005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 4.5] [Reference Citation Analysis]
175 Cohen JI, Nagy LE. Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells. J Dig Dis. 2011;12:3-9. [PMID: 21091930 DOI: 10.1111/j.1751-2980.2010.00468.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
176 Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013;94:93-103. [PMID: 23305254 DOI: 10.1111/iep.12008] [Cited by in Crossref: 153] [Cited by in F6Publishing: 133] [Article Influence: 19.1] [Reference Citation Analysis]
177 Thong-Ngam D, Samuhasaneeto S, Kulaputana O, Klaikeaw N. N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis. World J Gastroenterol 2007;13:5127-32. [PMID: 17876880 DOI: 10.3748/wjg.v13.i38.5127] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
178 Deng Z, Yan S, Hu H, Duan Z, Yin L, Liao S, Sun Y, Yin D, Li G. Proteomic profile of carbonylated proteins in rat liver: discovering possible mechanisms for tetracycline-induced steatosis. Proteomics 2015;15:148-59. [PMID: 25332112 DOI: 10.1002/pmic.201400115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
179 Hayashizaki-Someya Y, Kurosaki E, Takasu T, Mitori H, Yamazaki S, Koide K, Takakura S. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. Eur J Pharmacol. 2015;754:19-24. [PMID: 25701721 DOI: 10.1016/j.ejphar.2015.02.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
180 Wijesundera KK, Izawa T, Tennakoon AH, Golbar HM, Tanaka M, Kuwamura M, Yamate J. M1-/M2-macrophage polarization in pseudolobules consisting of adipohilin-rich hepatocytes in thioacetamide (TAA)-induced rat hepatic cirrhosis. Exp Mol Pathol. 2016;101:133-142. [PMID: 27453055 DOI: 10.1016/j.yexmp.2016.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
181 Geng T, Yang B, Li F, Xia L, Wang Q, Zhao X, Gong D. Identification of protective components that prevent the exacerbation of goose fatty liver: Characterization, expression and regulation of adiponectin receptors. Comp Biochem Physiol B Biochem Mol Biol 2016;194-195:32-8. [PMID: 26804769 DOI: 10.1016/j.cbpb.2016.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
182 Lake AD, Novak P, Shipkova P, Aranibar N, Robertson DG, Reily MD, Lehman-McKeeman LD, Vaillancourt RR, Cherrington NJ. Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. Amino Acids 2015;47:603-15. [PMID: 25534430 DOI: 10.1007/s00726-014-1894-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 12.7] [Reference Citation Analysis]
183 Ratziu V, Giral P, Munteanu M, Messous D, Mercadier A, Bernard M, Morra R, Imbert-Bismut F, Bruckert E, Poynard T. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia. Aliment Pharmacol Ther. 2007;25:207-218. [PMID: 17229244 DOI: 10.1111/j.1365-2036.2006.03182.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
184 Loffredo L, Del Ben M, Perri L, Carnevale R, Nocella C, Catasca E, Baratta F, Ceci F, Polimeni L, Gozzo P, Violi F, Angelico F. Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2016;44:279-86. [PMID: 27265388 DOI: 10.1111/apt.13687] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
185 Zhang HF, Shi LJ, Song GY, Cai ZG, Wang C, An RJ. Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation. Food Chem Toxicol 2013;55:70-7. [PMID: 23295629 DOI: 10.1016/j.fct.2012.12.043] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
186 Heyman-Lindén L, Seki Y, Storm P, Jones HA, Charron MJ, Berger K, Holm C. Berry intake changes hepatic gene expression and DNA methylation patterns associated with high-fat diet. J Nutr Biochem 2016;27:79-95. [PMID: 26423886 DOI: 10.1016/j.jnutbio.2015.08.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
187 Day CP. The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8:673-691, xi. [PMID: 15331069 DOI: 10.1016/j.cld.2004.04.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
188 Gupta R, Bhangoo A, Matthews NA, Anhalt H, Matta Y, Lamichhane B, Malik S, Narwal S, Wetzler G, Ten S. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J Pediatr Endocrinol Metab. 2011;24:907-911. [PMID: 22308841 DOI: 10.1515/jpem.2011.282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
189 Yamamoto K, Takahara K, Oyadomari S, Okada T, Sato T, Harada A, Mori K. Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol Biol Cell 2010;21:2975-86. [PMID: 20631254 DOI: 10.1091/mbc.E09-02-0133] [Cited by in Crossref: 198] [Cited by in F6Publishing: 152] [Article Influence: 18.0] [Reference Citation Analysis]
190 Hariri M, Gholami A, Mirhafez SR, Bidkhori M, Sahebkar A. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med 2020;51:102447. [PMID: 32507446 DOI: 10.1016/j.ctim.2020.102447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
191 Patton A, Church T, Wilson C, Thuma J, Goetz DJ, Berryman DE, List EO, Schwartz F, McCall KD. Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD. J Endocrinol 2018;237:337-51. [PMID: 29666152 DOI: 10.1530/JOE-18-0078] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
192 Willebrords J, Pereira IV, Maes M, Crespo Yanguas S, Colle I, Van Den Bossche B, Da Silva TC, de Oliveira CP, Andraus W, Alves VA. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res. 2015;59:106-125. [PMID: 26073454 DOI: 10.1016/j.plipres.2015.05.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 14.2] [Reference Citation Analysis]
193 Romestaing C, Piquet MA, Bedu E, Rouleau V, Dautresme M, Hourmand-Ollivier I, Filippi C, Duchamp C, Sibille B. Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutr Metab (Lond). 2007;4:4. [PMID: 17313679 DOI: 10.1186/1743-7075-4-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
194 Lau JK, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017;241:36-44. [PMID: 27757953 DOI: 10.1002/path.4829] [Cited by in Crossref: 162] [Cited by in F6Publishing: 144] [Article Influence: 32.4] [Reference Citation Analysis]
195 Magosso E, Ansari MA, Gopalan Y, Shuaib IL, Wong JW, Khan NA, Abu Bakar MR, Ng BH, Yuen KH. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutr J. 2013;12:166. [PMID: 24373555 DOI: 10.1186/1475-2891-12-166] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
196 Del Ben M, Polimeni L, Baratta F, Bartimoccia S, Carnevale R, Loffredo L, Pignatelli P, Violi F, Angelico F. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver. Int J Hepatol 2014;2014:784985. [PMID: 24678423 DOI: 10.1155/2014/784985] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
197 Kamari Y, Shaish A, Vax E, Shemesh S, Kandel-Kfir M, Arbel Y, Olteanu S, Barshack I, Dotan S, Voronov E. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol. 2011;55:1086-1094. [PMID: 21354232 DOI: 10.1016/j.jhep.2011.01.048] [Cited by in Crossref: 171] [Cited by in F6Publishing: 156] [Article Influence: 17.1] [Reference Citation Analysis]
198 Hyatt MA, Gardner DS, Sebert S, Wilson V, Davidson N, Nigmatullina Y, Chan LL, Budge H, Symonds ME. Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring. Reproduction 2011;141:119-26. [PMID: 21045167 DOI: 10.1530/REP-10-0325] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
199 Kang C, Jin YB, Lee H, Cha M, Sohn E, Moon J, Park C, Chun S, Jung E, Hong J, Kim SB, Kim J, Kim E. Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food and Chemical Toxicology 2010;48:509-16. [DOI: 10.1016/j.fct.2009.11.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
200 Zarkovic K, Jakovcevic A, Zarkovic N. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases. Free Radic Biol Med 2017;111:110-26. [PMID: 27993730 DOI: 10.1016/j.freeradbiomed.2016.12.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
201 Abdel-Razik A, Mousa N, Shabana W, Refaey M, ElMahdy Y, Elhelaly R, Elzehery R, Zalata K, Arafa M, Elbaz S, Hafez M, Awad M. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study. Eur J Gastroenterol Hepatol. 2016;28:e1-9. [PMID: 26469357 DOI: 10.1097/meg.0000000000000486] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
202 Gentilucci UV, Santini D, Vincenzi B, Fiori E, Picardi A, Tonini G. Chemotherapy-induced steatohepatitis in colorectal cancer patients. J Clin Oncol. 2006;24:5467; author reply 5467-5468. [PMID: 17135651 DOI: 10.1200/jco.2006.08.1828] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
203 Hardwick RN, Cherrington NJ. Measuring altered disposition of xenobiotics in experimental models of liver disease. Curr Protoc Toxicol. 2012;Chapter 23:Unit 23.1. [PMID: 22549269 DOI: 10.1002/0471140856.tx2301s52] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
204 Froylich D, Corcelles R, Daigle C, Boules M, Brethauer S, Schauer P. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Surg Obes Relat Dis. 2016;12:127-131. [PMID: 26077701 DOI: 10.1016/j.soard.2015.04.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
205 Schindhelm RK, Diamant M, Bakker SJ, van Dijk RA, Scheffer PG, Teerlink T, Kostense PJ, Heine RJ. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur J Clin Invest 2005;35:369-74. [PMID: 15948897 DOI: 10.1111/j.1365-2362.2005.01502.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
206 Kumazawa M, Kobayashi M, Io F, Kawai T, Nishimura M, Ohno T, Horio F. Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet. J Lipid Res 2007;48:2039-46. [PMID: 17595448 DOI: 10.1194/jlr.M700222-JLR200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
207 Vuković R, Blažetić S, Oršolić I, Heffer M, Vari SG, Gajdoš M, Krivošíková Z, Kramárová P, Kebis A, Has-Schön E. Impact of ovariectomy, high fat diet, and lifestyle modifications on oxidative/antioxidative status in the rat liver. Croat Med J 2014;55:218-27. [PMID: 24891280 DOI: 10.3325/cmj.2014.55.218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
208 Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004;126:586-597. [PMID: 14762795 DOI: 10.1053/j.gastro.2003.11.020] [Cited by in Crossref: 318] [Cited by in F6Publishing: 293] [Article Influence: 18.7] [Reference Citation Analysis]
209 Gauthier MS, Favier R, Lavoie JM. Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr. 2006;95:273-281. [PMID: 16469142 DOI: 10.1079/BJN20051635] [Cited by in Crossref: 76] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
210 Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103:71-83. [PMID: 19914930 DOI: 10.1093/qjmed/hcp158] [Cited by in Crossref: 392] [Cited by in F6Publishing: 348] [Article Influence: 32.7] [Reference Citation Analysis]
211 Hassan W, Rongyin G, Daoud A, Ding L, Wang L, Liu J, Shang J. Reduced oxidative stress contributes to the lipid lowering effects of isoquercitrin in free fatty acids induced hepatocytes. Oxid Med Cell Longev. 2014;2014:313602. [PMID: 25404990 DOI: 10.1155/2014/313602] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
212 Damelin LH, Coward S, Kirwan M, Collins P, Selden C, Hodgson HJ. Fat-loaded HepG2 spheroids exhibit enhanced protection from Pro-oxidant and cytokine induced damage. J Cell Biochem 2007;101:723-34. [PMID: 17211854 DOI: 10.1002/jcb.21229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
213 Tashiro K, Takai S, Jin D, Yamamoto H, Komeda K, Hayashi M, Tanaka K, Tanigawa N, Miyazaki M. Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet. Hepatol Res. 2010;40:514-523. [PMID: 20374300 DOI: 10.1111/j.1872-034X.2010.00627.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
214 Lim SM, Kim E, Shin JH, Seok PR, Jung S, Yoo SH, Kim Y. Xylobiose Prevents High-Fat Diet Induced Mice Obesity by Suppressing Mesenteric Fat Deposition and Metabolic Dysregulation. Molecules 2018;23:E705. [PMID: 29558403 DOI: 10.3390/molecules23030705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
215 Levene AP, Goldin RD. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology. 2012;61:141-152. [PMID: 22372457 DOI: 10.1111/j.1365-2559.2011.04145.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 12.7] [Reference Citation Analysis]
216 Ratziu V, Poynard T. Assessing the outcome of nonalcoholic steatohepatitis? It’s time to get serious. Hepatology. 2006;44:802-805. [PMID: 17006914 DOI: 10.1002/hep.21391] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
217 Rouvinen-Watt K, Pal C, Martin T, Harris L, Astatkie T, Kryzskaya D, Kärjä V, Mustonen AM, Tammi R, Tammi M, Nieminen P. Evidence of endoplasmic reticulum stress and liver inflammation in the American mink Neovison vison with benign hepatic steatosis. J Comp Physiol B 2014;184:913-27. [PMID: 25079677 DOI: 10.1007/s00360-014-0845-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
218 Cua IH, George J. Non-alcoholic fatty liver disease. Hosp Med 2005;66:106-11. [PMID: 15739708 DOI: 10.12968/hmed.2005.66.2.17559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
219 Hui ST, Parks BW, Org E, Norheim F, Che N, Pan C, Castellani LW, Charugundla S, Dirks DL, Psychogios N, Neuhaus I, Gerszten RE, Kirchgessner T, Gargalovic PS, Lusis AJ. The genetic architecture of NAFLD among inbred strains of mice. Elife 2015;4:e05607. [PMID: 26067236 DOI: 10.7554/eLife.05607] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 9.7] [Reference Citation Analysis]
220 Parafati M, Lascala A, Morittu VM, Trimboli F, Rizzuto A, Brunelli E, Coscarelli F, Costa N, Britti D, Ehrlich J. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome. J Nutr Biochem. 2015;26:938-948. [PMID: 26025327 DOI: 10.1016/j.jnutbio.2015.03.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
221 Ahima RS. The natural history of nonalcoholic fatty liver disease: insights from children and mice. Gastroenterology 2008;135:1860-2. [PMID: 19000676 DOI: 10.1053/j.gastro.2008.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
222 Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 2007;13:361-8. [PMID: 17230603 DOI: 10.3748/wjg.v13.i3.361] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
223 Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 2006;26:1021-1028. [PMID: 17032401 DOI: 10.1111/j.1478-3231.2006.01323.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 7.9] [Reference Citation Analysis]
224 Lin X, Chen Z, Yue P, Averna MR, Ostlund RE Jr, Watson MA, Schonfeld G. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation. Am J Physiol Gastrointest Liver Physiol 2006;290:G1170-6. [PMID: 16455790 DOI: 10.1152/ajpgi.00402.2005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
225 Rodrigues MF, Stotzer US, Domingos MM, Deminice R, Shiguemoto GE, Tomaz LM, Sousa NM, Ferreira FC, Leite RD, Selistre-de-Araújo HS, Jordão-Júnior AA, Baldissera V, Perez SE. Effects of ovariectomy and resistance training on oxidative stress markers in the rat liver. Clinics (Sao Paulo) 2013;68:1247-54. [PMID: 24141842 DOI: 10.6061/clinics/2013(09)12] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
226 Gan L, Xiang W, Xie B, Yu L. Molecular mechanisms of fatty liver in obesity. Front Med 2015;9:275-87. [PMID: 26290284 DOI: 10.1007/s11684-015-0410-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
227 Yunianingtias D, Volker D. Nutritional aspects of non-alcoholic steatohepatitis treatment. Nutrition & Dietetics 2006;63:79-90. [DOI: 10.1111/j.1747-0080.2006.00054.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
228 Serviddio G, Giudetti AM, Bellanti F, Priore P, Rollo T, Tamborra R, Siculella L, Vendemiale G, Altomare E, Gnoni GV. Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS One. 2011;6:e24084. [PMID: 21909411 DOI: 10.1371/journal.pone.0024084] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 8.1] [Reference Citation Analysis]
229 Li J, Sapper TN, Mah E, Rudraiah S, Schill KE, Chitchumroonchokchai C, Moller MV, McDonald JD, Rohrer PR, Manautou JE, Bruno RS. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet. Mol Nutr Food Res 2016;60:858-70. [PMID: 26679056 DOI: 10.1002/mnfr.201500814] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
230 Inafuku M, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama H, Toda T, Yanagita T. Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. Br J Nutr 2012;107:639-46. [PMID: 21787451 DOI: 10.1017/S0007114511003485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
231 Chung MY, Park HJ, Manautou JE, Koo SI, Bruno RS. Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem 2012;23:361-7. [PMID: 21543212 DOI: 10.1016/j.jnutbio.2011.01.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
232 Baumgardner JN, Shankar K, Hennings L, Badger TM, Ronis MJ. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol. 2008;294:G27-G38. [PMID: 17947452 DOI: 10.1152/ajpgi.00296.2007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
233 Del Ben M, Baratta F, Polimeni L, Angelico F. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Intern Emerg Med. 2012;7 Suppl 3:S291-S296. [PMID: 23073870 DOI: 10.1007/s11739-012-0819-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
234 Jung TS, Kim SK, Shin HJ, Jeon BT, Hahm JR, Roh GS. α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. Liver Int. 2012;32:1565-1573. [PMID: 22863080 DOI: 10.1111/j.1478-3231.2012.02857.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
235 Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut. 2005;54:987-993. [PMID: 15951547 DOI: 10.1136/gut.2004.057968] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 8.4] [Reference Citation Analysis]
236 Lin X, Yue P, Chen Z, Schonfeld G. Hepatic triglyceride contents are genetically determined in mice: results of a strain survey. Am J Physiol Gastrointest Liver Physiol 2005;288:G1179-89. [PMID: 15591160 DOI: 10.1152/ajpgi.00411.2004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
237 Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 2015;7:1679-84. [PMID: 26140087 DOI: 10.4254/wjh.v7.i12.1679] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
238 Perera N, Indrakumar J, Abeysinghe WV, Fernando V, Samaraweera WM, Lawrence JS. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka. BMC Cardiovasc Disord. 2016;16:37. [PMID: 26869052 DOI: 10.1186/s12872-016-0212-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
239 Siddiqui RA, Xu Z, Harvey KA, Pavlina TM, Becker MJ, Zaloga GP. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content. Nutr Metab (Lond) 2015;12:41. [PMID: 26583036 DOI: 10.1186/s12986-015-0038-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
240 Makovicky P, Dudova M, Tumova E, Rajmon R, Vodkova Z. Experimental study of non-alcoholic fatty liver disease (NAFLD) on a model of starving chickens: Is generalization of steatosis accompanied by fibrosis of the liver tissue? Pathology - Research and Practice 2011;207:151-5. [DOI: 10.1016/j.prp.2010.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
241 Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem? Journal of Hepatology 2007;46:1133-42. [DOI: 10.1016/j.jhep.2007.03.003] [Cited by in Crossref: 123] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
242 Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Mol Metab 2017;6:138-47. [PMID: 28123944 DOI: 10.1016/j.molmet.2016.11.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 10.2] [Reference Citation Analysis]
243 Chen YJ, Wallig MA, Jeffery EH. Dietary Broccoli Lessens Development of Fatty Liver and Liver Cancer in Mice Given Diethylnitrosamine and Fed a Western or Control Diet. J Nutr 2016;146:542-50. [PMID: 26865652 DOI: 10.3945/jn.115.228148] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
244 Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005;50:2338-43. [PMID: 16416185 DOI: 10.1007/s10620-005-3058-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
245 Ahima RS. Insulin Resistance: Cause or Consequence of Nonalcoholic Steatohepatitis? Gastroenterology 2007;132:444-6. [DOI: 10.1053/j.gastro.2006.11.048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
246 Serin E, Güçlü M, Ataç FB, Verdi H, Kayaselçuk F, Ozer B, Bilezikçi B, Yilmaz U. Methylenetetrahydrofolate reductase C677T mutation and nonalcoholic fatty liver disease. Dig Dis Sci. 2007;52:1183-1186. [PMID: 17356914 DOI: 10.1007/s10620-006-9565-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
247 Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Adv Ther. 2017;34:1291-1326. [PMID: 28526997 DOI: 10.1007/s12325-017-0556-1] [Cited by in Crossref: 197] [Cited by in F6Publishing: 163] [Article Influence: 49.3] [Reference Citation Analysis]
248 Ortiz-Avila O, Gallegos-Corona MA, Sánchez-Briones LA, Calderón-Cortés E, Montoya-Pérez R, Rodriguez-Orozco AR, Campos-García J, Saavedra-Molina A, Mejía-Zepeda R, Cortés-Rojo C. Protective effects of dietary avocado oil on impaired electron transport chain function and exacerbated oxidative stress in liver mitochondria from diabetic rats. J Bioenerg Biomembr 2015;47:337-53. [PMID: 26060181 DOI: 10.1007/s10863-015-9614-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
249 Sharma MR, Polavarapu R, Roseman D, Patel V, Eaton E, Kishor PB, Nanji AA. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis. Exp Mol Pathol 2006;81:202-10. [PMID: 16949573 DOI: 10.1016/j.yexmp.2006.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
250 Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4:51-63. [PMID: 23772273 DOI: 10.4239/wjd.v4.i3.51] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 63] [Article Influence: 11.3] [Reference Citation Analysis]
251 Sharma MR, Polavarapu R, Roseman D, Patel V, Eaton E, Kishor PB, Nanji AA. Increased severity of alcoholic liver injury in female verses male rats: a microarray analysis. Exp Mol Pathol. 2008;84:46-58. [PMID: 18062962 DOI: 10.1016/j.yexmp.2007.10.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
252 Alkhouri N, Feldstein AE. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? Metabolism. 2016;65:1087-1095. [PMID: 26972222 DOI: 10.1016/j.metabol.2016.01.013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
253 Matsumoto T, Terai S, Oishi T, Kuwashiro S, Fujisawa K, Yamamoto N, Fujita Y, Hamamoto Y, Furutani-Seiki M, Nishina H, Sakaida I. Medaka as a model for human nonalcoholic steatohepatitis. Dis Model Mech 2010;3:431-40. [PMID: 20371730 DOI: 10.1242/dmm.002311] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
254 Georgoulis M, Fragopoulou E, Kontogianni MD, Margariti A, Boulamatsi O, Detopoulou P, Tiniakos D, Zafiropoulou R, Papatheodoridis G. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity. Nutr Res 2015;35:41-8. [PMID: 25530013 DOI: 10.1016/j.nutres.2014.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
255 Feldstein AE, Lopez R, Tamimi TA, Yerian L, Chung YM, Berk M, Zhang R, McIntyre TM, Hazen SL. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res. 2010;51:3046-3054. [PMID: 20631297 DOI: 10.1194/jlr.m007096] [Cited by in Crossref: 170] [Cited by in F6Publishing: 84] [Article Influence: 15.5] [Reference Citation Analysis]
256 Christensen KE, Wu Q, Wang X, Deng L, Caudill MA, Rozen R. Steatosis in Mice Is Associated with Gender, Folate Intake, and Expression of Genes of One-Carbon Metabolism. The Journal of Nutrition 2010;140:1736-41. [DOI: 10.3945/jn.110.124917] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
257 Barrow RE, Hawkins HK, Aarsland A, Cox R, Rosenblatt J, Barrow LN, Jeschke MG, Herndon DN. Identification of factors contributing to hepatomegaly in severely burned children. Shock 2005;24:523-8. [PMID: 16317382 DOI: 10.1097/01.shk.0000187981.78901.ee] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
258 Mager DR, Mazurak V, Rodriguez-Dimitrescu C, Vine D, Jetha M, Ball G, Yap J. A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease. JPEN J Parenter Enteral Nutr 2013;37:517-28. [PMID: 23223552 DOI: 10.1177/0148607112467820] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
259 Lee E, Lim Y, Kwon SW, Kwon O. Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. The Journal of Nutritional Biochemistry 2019;68:33-41. [DOI: 10.1016/j.jnutbio.2019.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
260 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. Pathologe. 2010;31:225-237. [PMID: 20221762 DOI: 10.1007/s00292-010-1298-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
261 Sardana O, Goyal R, Bedi O. Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. Inflammopharmacology 2021;29:1061-74. [PMID: 34185201 DOI: 10.1007/s10787-021-00837-4] [Reference Citation Analysis]
262 Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, Podevin P, Lacorte JM, Bernhardt C, Bruckert E, Grimaldi A, Poynard T;  LIDO Study Group. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology. 2008;135:100-110. [PMID: 18503774 DOI: 10.1053/j.gastro.2008.03.078] [Cited by in Crossref: 421] [Cited by in F6Publishing: 373] [Article Influence: 32.4] [Reference Citation Analysis]